SPONSORED CONTENT
Part 2 of 2: Navigating staffing shortages, unpredictable demand, and complex industry requirements
While in-house pharmacies offer a wide array of benefits both for the community health center (CHC) and their patient
…Articles by : Sponsored Content,
Q: Where did you grow up?
Queensbury NY
Q: Where did you go to college?
Castleton University for Undergrad and SUNY Albany for Graduate School
Q: What are your favorites?
Food: Sushi
Movie: I can’t box myself in to just one. In no particular order: The Big Short, LOTR: The Two Towers, Parasite
Musicians: My last 3
…
SPONSORED CONTENT
Part 1 of 2: Managing costs and ensuring favorable contracting
As industry veterans know too well, having an in-house pharmacy can be greatly beneficial for both community health centers (CHCs) and
…
SPONSORED CONTENT
TIP: Expand your Ryan White 340B designation to include STDs to improve patient health outcomes and maximize your 340B savings.
SPONSORED CONTENT
Last week, the 340B community gathered in the sun-soaked city of San Diego to gain insights, exchange best practices, and navigate the evolving complexities surrounding the program. Whether you missed the 340B Coalition winter event altogether or are seeking a recap to share
…
SPONSORED CONTENT
TIP: Ensure your organization complies with the new 340B billing modifier requirements effective in 2024 and 2025.
SPONSORED CONTENT
The Health Resources and Services Administration (HRSA) conducts randomized audits to assess compliance with the 340B drug pricing program, a federal initiative aimed at providing discounted medications to eligible entities. With more than 13,100 parent entities participating in 340B, this increased
…
SPONSORED CONTENT
Are you truly ready for a HRSA audit? Today we have two 340B experts, Dennis Killian and Heather Erickson, from CPS Solutions, LLC. (CPS) here to discuss three topics that will help you prepare. CPS has managed 340B Programs for hospitals and health systems since the
…
SPONSORED CONTENT
In the complex landscape of healthcare, the 340B program plays a vital role in ensuring that vulnerable patients with limited financial resources have access to affordable medications. It enables qualified covered entities to maximize their resources and offer a wider range of benefits and services
…SPONSORED CONTENT
Join our webinar for a comprehensive exploration of the current status of the 340B program, featuring a review of major industry trends from 2023 and key developments anticipated for 2024.
We’ll discuss what entities should expect and prepare for in the upcoming year,